Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00019201 · ClinicalTrials.gov registry record · NA
Fluorescent Light Bronchoscopy Plus White Light Bronchoscopy for Early Detection of Lung Cancer
A NA study of Lung Cancer and Head and Neck Cancer, sponsored by National Cancer Institute (NCI).
- Completed
- Registry status
- NA
- Development phase
- 1
- Study location
NCT00019201 is a NA study of Lung Cancer and Head and Neck Cancer that has completed, run by National Cancer Institute (NCI). The trial reports 1 study location across 1 state.
The verdict
NCT00019201, a NA study of Lung Cancer and Head and Neck Cancer, has completed, sponsored by National Cancer Institute (NCI).
- COMPLETED
- Registry status
- NA
- Development phase
- 1
- Study location
Study Summary
RATIONALE: Fluorescent bronchoscopy, when used in combination with conventional white light bronchoscopy, may improve the ability to detect early lung cancer. PURPOSE: A pilot study to evaluate fluorescent light bronchoscopy plus conventional bronchoscopy as a tool for screening and detecting lung cancer in persons with completely resected head and neck cancer or successfully treated early-stage lung cancer.
Conditions Studied
Interventions
- OTHER cytology specimen collection procedure
- OTHER immunohistochemistry staining method
- OTHER sputum cytology
- PROCEDURE bronchoscopy
- PROCEDURE bronchoscopic and lung imaging studies
Study Locations (1)
Maryland
- Warren Grant Magnuson Clinical Center - NCI Clinical Studies Support - Bethesda
Trial Details
| Field | Value |
|---|---|
| Start Date | 1996-08 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00019201
The ClinicalTrials.gov registry entry for NCT00019201 describes a study currently listed as completed, categorized as NA. An enrollment target was not published in the registry record, which is common for early-stage or observational entries. The listed sponsor is National Cancer Institute (NCI), which has 3,257 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Lung Cancer appearing as the primary indexed condition, and to 5 interventions - of which cytology specimen collection procedure is the first listed.
NCT00019201 reports 1 study location spanning 1 distinct geographic area - top geographies include Maryland.
Frequently Asked Questions
What is clinical trial NCT00019201 about?
NCT00019201 is a clinical study titled "Fluorescent Light Bronchoscopy Plus White Light Bronchoscopy for Early Detection of Lung Cancer". RATIONALE: Fluorescent bronchoscopy, when used in combination with conventional white light bronchoscopy, may improve the ability to detect early lung cancer. PURPOSE: A pilot study to evaluate fluorescent light bronchoscopy plus conventional bronchoscopy as a tool for screening and detecting lung ...
What is the current status of trial NCT00019201?
This trial is currently completed. It is a NA study. The study started on 1996-08.
What conditions does trial NCT00019201 study?
This clinical trial studies the following conditions: Lung Cancer, Head and Neck Cancer.
What interventions are being tested in trial NCT00019201?
The interventions under investigation include: cytology specimen collection procedure (OTHER), immunohistochemistry staining method (OTHER), sputum cytology (OTHER), bronchoscopy (PROCEDURE), bronchoscopic and lung imaging studies (PROCEDURE).
Who is sponsoring clinical trial NCT00019201?
This trial is sponsored by National Cancer Institute (NCI), which has 3,257 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00019201 being conducted?
This trial has 1 study location across Maryland. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Lung Cancer
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Lung B.A.S.E.S. 4 Life Mobile Low-dose Computed Tomography (LDCT) Screening: Ages 40-54
RECRUITING · NA
-
Lung Cancer Screening in High-risk Black Individuals
RECRUITING · NA
-
A Patient and Provider Intervention to Address Health Disparities in Lung Cancer Screening
RECRUITING · NA
-
Exercise as Maintenance Therapy in Advanced Lung Cancer
RECRUITING · NA
-
Improving Care for Rural Patients With Solid Tumors
RECRUITING · NA
-
Stereotactic Magnetic Resonance Guided Radiation Therapy
RECRUITING · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.